Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC. - Hensing TA; Wang X; Stinchcombe TE; Gao J; Knopp MV; Watson M; Dudek AZ; Graziano SL; Patel JD; Faller BA; Dragnev KH; Kozono D; et al. (JTO clinical and research reports, 2021)